2017 was a busy year for healthcare mergers and acquisitions, with 1,566 transactions announced. At this early date, that total is 2% below the previous year’s total of 1,593 (a record year, by the way). Private equity firms contributed to that total, announcing 158 transactions, or 10% of the annual total, according to data obtained […]
After 34 announced transactions in 2017, the news that one contract research organization (CRO) bought another CRO is downright yawn-inducing. This space is undergoing rapid consolidation, no question. Before this week, those 34 deals had a combined total of approximately $20.9 billion. Add another deal, and another $950 million, and the market just got a […]
In late July, Laboratory Corp. of America Holdings (NYSE: LH) announced the 6th CRO deal to surpass the $1 billion mark this year. The $1.2 billion deal for Chiltern is its third announced transaction this year, having acquired Mount Sinai’s Clinical Outreach Laboratories (January) and Pathology Associates Medical Laboratories, LLC (February).
A portfolio company of KKR (NYSE: KKR) just announced the 99th eHealth deal of 2017, and the second largest eHealth deal in our M&A database dating back to 1993.
The CRO market is a favorite of private equity investors, and M&A activity has been strong in the first half of 2017.
Private equity firms are taking big stakes in contract research organizations in 2017.
Deals for contract research organizations (CROs) surged 157% in 2016.
Sheridan just made its fifth announced acquisition of the year, buying Premier Emergency Medical Specialists, a 49-physician group in Phoenix, Arizona. Sheridan is the Physician Services division of AmSurg Corp. (NASDAQ: AMSG), the ambulatory surgery giant, which last year paid $2.35 billion for Sheridan, then a portfolio company of Hellman & Friedman. The purchase marks […]
